FICCI

The British Chamber of Commerce recently convened a panel discussion on “India: How to Take Advantage of the Free Trade Agreement.” Moderated by FICCI, the session brought together a distinguished lineup of experts, offering a comprehensive 360-degree perspective on the evolving India-UK trade corridor. With the UK–India Free Trade Agreement now nearing implementation, the discussion focused on the practical aspects of execution and how businesses can meaningfully leverage emerging opportunities.    In his remarks, H.E Vikram K. Doraiswamy, High Commissioner of India to the United Kingdom, highlighted India’s rapid digital transformation, positioning it as an indispensable destination for UK businesses. He underscored the importance of moving beyond transactional trade towards building deep, enduring partnerships.    The panel also featured Aileen Keyes, Director, International Tax & Trade at Diageo, and Iain Walker, Industry Engagement Director at GS1 UK, who shared valuable insights on how businesses can effectively maximise the benefits of the FTA.   The message was clear: the structural bridge is now open. As India continues to emerge as one of the world’s most dynamic growth engines, it represents a future market that global businesses cannot afford to overlook. At its core, the FTA is not just about trade- it is about fostering long-term partnerships that enable both nations to grow and prosper together.  

The Indian Council of Arbitration is delighted to share that Mr. Arun Chawla, Director General of the Indian Council of Arbitration & former DG, FICCI alongside Dr. Pinky Anand, Senior Advocate, SCI & Former ASG of India, and Ms. Manjaree Chowdhary, General Counsel at Maruti Suzuki India Limited, spoke at a podcast by The Bar Bulletin on "India’s growth story – policy, law, and dispute resolution". In the podcast, the discussion offered a thought-provoking deliberation on how policy stability, legal certainty, and robust arbitration and dispute resolution frameworks are shaping India’s journey toward Viksit Bharat. It examined the profound implications for investor confidence, judicial consistency, corporate decision-making, and governance, providing deep insights at the intersection of policy, law, and industry. The complete podcast can be accessed via the link below https://lnkd.in/g4kBm3Nu Narendra Modi| Arjun Ram Meghwal|Piyush Goyal| Ministry of Law and Justice|Ministry of Commerce and Industry, Government of India| Supreme Court of India| High Court of Delhi|Khaitan & Co| Arun Chawla|Dr. Pinky Anand| Manjaree Chowdhary| FICCI| Bar and Bench| The Bar Bulletin

Mr. Winselow Tucker, Co- Chair, FICCI Pharma Commitee & President and General Manager, Eli Lilly & company (India), will be speaking at Plenary Session 6: "Reflections and Big Moves to Leapfrog Innovation" at India Pharma 2026. The session “Reflections and Big Moves to Leapfrog Innovation” will explore the bold strategies needed for India’s next phase of pharmaceutical growth, with a strong focus on innovation, advanced therapies, and R&D. The session will also highlight the role of policy, partnerships, and investment in building a globally competitive innovation ecosystem. Register now. Registration Link: https://lnkd.in/g2hVTaNz 📅 13th & 14th April 2026 📍 FICCI Federation House, New Delhi #IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

India’s energy story is inseparable from its growth trajectory. The government has made decisive strides—achieving 250 GW of non-fossil fuel capacity, reaching 50% renewable power generation five years ahead of target, advancing the National Green Hydrogen Mission, Shanti bill’s passage and scaling ethanol blending to 18–20%. In the short term, we must manage supply shocks through trade facilitation and alternative routes. The medium-term focus should be on expanding Strategic Petroleum Reserves and scaling domestic manufacturing of solar modules, batteries, and critical minerals. Long-term resilience hinges on accelerating domestic oil and gas exploration, expanding nuclear power, and building offshore wind, pumped hydro storage, advanced battery tech and green hydrogen capacity. This isn’t merely about reducing imports but about creating a resilient energy ecosystem for the future, writes FICCI Director General, Ms Jyoti Vij in Mint.

The session “Reflections and Big Moves to Leapfrog Innovation” sets the stage for India’s next leap in pharmaceutical excellence. As the nation evolves beyond its legacy as the “Pharmacy of the World,” the focus shifts to bold investments in breakthrough R&D, biologics, and AI-driven drug discovery. This session explores actionable strategies in policy, partnerships, and capability building to drive innovation-led growth. A step forward in shaping a future aligned with the vision of Viksit Bharat. Join industry experts at the 9th edition of India Pharma 2026, organised by the Department of Pharmaceuticals, Government of India, in association with FICCI and the Indian Pharmaceutical Alliance (IPA). Register now. Registration Link: https://lnkd.in/g2hVTaNz 📅 13th & 14th April 2026 📍 FICCI Federation House, New Delhi #IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

FICCI - West Bengal State Council is organizing a Seminar on ‘Silver Economy and Healthy Ageing’ on 10 April 2026 in Kolkata.  The seminar will focus on building integrated, community-based eldercare ecosystems, covering geriatric care, senior living innovations, home-based and long-term care, and the role of preventive health in enhancing quality of life. It will bring together key stakeholders across healthcare, senior living, and allied sectors to explore sustainable models for healthy, active, and dignified ageing. For registration kindly click on the following link: https://lnkd.in/gj8xq3T6 #SilverEconomy #HealthyAgeing #Eldercare InfinityGroup Jagriti Dham Life Insurance Corporation of India KITES Senior Care Serene Communities by Columbia Pacific Amway India Enterprises Private Limited MAITYS Sonali Ghosal Xelpmoc Design and Tech Limited

Mr. Kartik Rajendran, Co-Chair, FICCI Pharma Committee & Managing Director, Abbott India, will be speaking at Plenary Session 1: “Policy Thrust for Catalysing Innovation” at India Pharma 2026. This session will focus on building a forward-looking policy ecosystem to drive innovation, encourage investment, and position India as a global life sciences leader. Join the leaders shaping the future of pharma at the 9th edition of India Pharma 2026, organised by the Department of Pharmaceuticals, Government of India, in association with FICCI and the Indian Pharmaceutical Alliance (IPA). Register now. Registration Link: https://lnkd.in/g2hVTaNz 📅 13th & 14th April 2026 📍 FICCI Federation House, New Delhi #IndiaPharma2026 #IndiaPharma #PharmaConference #PharmaLeadership #LifeSciences

India’s manufacturing ecosystem is deeply embedded in global supply chains. From energy and fertilizers to electronics and chemicals, several sectors rely heavily on imported raw materials and intermediates. Recent geopolitical developments have reinforced the need for building long-term resilience through reduced import dependence. Supply chain resilience cannot be built through isolated interventions—it requires an integrated, forward-looking approach involving government, industry, and global partners, writes FICCI President, Mr Anant Goenka in The Hindu.